Compare Humana Inc (HUM) vs SpaceX (SPCX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Humana Inc vs SpaceX — how do they compare? Humana Inc trades at $373.38 (market cap $46.31B), while SpaceX trades at $133.29 (market cap $1.83T). The key difference: SpaceX is far larger — about 39.5× Humana Inc's market cap, and Humana Inc pays a 0.92% dividend while SpaceX pays none. Which is the better fit depends on your goals.
| HUM | SPCX | |
|---|---|---|
Market Cap | $46.31B | $1.83T |
Sector | Health | Technology |
52-Week High | $409.42 | $202.09 |
52-Week Low | $163.67 | $108.27 |
Enterprise Value | $53.67B | $1.77T |
Dividend Yield | 0.92% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Humana (HUM) trades at $385.00, up 4.82% today, with a bullish technical outlook and analyst consensus price target of $399.53. Recent earnings beats in Q1 and Q2 2026, alongside revenue growth to $129.66 billion in 2025, support fundamentals, though net margins have compressed. The company is expanding its Medicaid business and targeting margin improvements by 2027.
The stock offers upside to consensus targets but faces risks from Medicare Advantage margin pressures and regulatory changes. Profitability trends are weak despite revenue growth, requiring successful cost management to meet 2028 targets. Institutional sentiment is mixed with a majority hold rating.
SpaceX (SPCX) trades at $133.11, up 15.83% in 24 hours, reclaiming its $135 IPO price amid bullish technical signals and positive analyst sentiment. The stock shows strong momentum with resistance near $140 and support at $121. Despite negative profitability margins and high valuation ratios, robust revenue growth and significant capital investments in AI and infrastructure signal long-term ambition. Recent news highlights a major chip plant investment and a new satellite launch contract, fueling investor optimism.
Outlook is cautiously optimistic with a consensus price target of $228.52, though risks include persistent losses, high capex, and competitive pressures. The stock offers growth potential driven by Starlink's performance and strategic expansions, but investors must weigh volatility and execution risks against bullish analyst coverage.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Humana Inc
Humana is one of the largest private health insurers in the U.S. with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Humana offers employer-based plans primarily for small businesses along with specialty insurance offerings such as dental, vision, and life. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
Read more on HUM →About SpaceX
SpaceX is the world's leading aerospace manufacturer and launch provider. It designs and operates reusable rockets, spacecraft, and Starlink, a global satellite internet service with over 10 million subscribers across 160 countries.
Read more on SPCX →
